Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of the American Chemical Society
|
May 31, 2011
Total synthesis of bryostatin 9
Paul A Wender, Adam J Schrier
Journal of the American Chemical Society
|
May 3, 2008
Efficient synthetic access to a new family of highly potent bryostatin analogues via a Prins-driven macrocyclization strategy
Paul A Wender, Brian A Dechristopher, Adam J Schrier
Israel Journal of Chemistry
|
June 5, 2012
Translating Nature's Library: The Bryostatins and Function-Oriented Synthesis
Paul A Wender, Brian A Loy, Adam J Schrier
Experimental Hematology
|
April 3, 2012
Bryostatin analogue-induced apoptosis in mantle cell lymphoma cell lines
Ana Lopez-Campistrous, Xiaohua Song, Adam J Schrier, et al.
Nature Chemistry
|
August 24, 2012
Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro
Brian A DeChristopher, Brian A Loy, Matthew D Marsden, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 19, 2011
Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity
Paul A Wender, Jeremy L Baryza, Stacey E Brenner, et al.
Journal of Natural Products
|
February 23, 2016
Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death
Daryl Staveness, Rana Abdelnabi, Adam J Schrier, et al.
Plos Pathogens
|
September 22, 2017
In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication
Matthew D Marsden, Brian A Loy, Xiaomeng Wu, et al.
Virology
|
May 26, 2018
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
Matthew D Marsden, Xiaomeng Wu, Sara M Navab, et al.
Journal of Medicinal Chemistry
|
December 22, 2025
Discovery of Bis-Acyl Hydrazides as Potent and Bioavailable MTA-Cooperative PRMT5 Inhibitors: A Case Study of Leveraging the Deuterium Kinetic Isotope Effect
Laurent Debien, Megan K Armstrong, Joshua D Farr, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of the American Chemical Society
|
May 31, 2011
Total synthesis of bryostatin 9
Paul A Wender, Adam J Schrier
Journal of the American Chemical Society
|
May 3, 2008
Efficient synthetic access to a new family of highly potent bryostatin analogues via a Prins-driven macrocyclization strategy
Paul A Wender, Brian A Dechristopher, Adam J Schrier
Israel Journal of Chemistry
|
June 5, 2012
Translating Nature's Library: The Bryostatins and Function-Oriented Synthesis
Paul A Wender, Brian A Loy, Adam J Schrier
Experimental Hematology
|
April 3, 2012
Bryostatin analogue-induced apoptosis in mantle cell lymphoma cell lines
Ana Lopez-Campistrous, Xiaohua Song, Adam J Schrier, et al.
Nature Chemistry
|
August 24, 2012
Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro
Brian A DeChristopher, Brian A Loy, Matthew D Marsden, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 19, 2011
Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity
Paul A Wender, Jeremy L Baryza, Stacey E Brenner, et al.
Journal of Natural Products
|
February 23, 2016
Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death
Daryl Staveness, Rana Abdelnabi, Adam J Schrier, et al.
Plos Pathogens
|
September 22, 2017
In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication
Matthew D Marsden, Brian A Loy, Xiaomeng Wu, et al.
Virology
|
May 26, 2018
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
Matthew D Marsden, Xiaomeng Wu, Sara M Navab, et al.
Journal of Medicinal Chemistry
|
December 22, 2025
Discovery of Bis-Acyl Hydrazides as Potent and Bioavailable MTA-Cooperative PRMT5 Inhibitors: A Case Study of Leveraging the Deuterium Kinetic Isotope Effect
Laurent Debien, Megan K Armstrong, Joshua D Farr, et al.
Page
of 1